Loading-associated Expression of TRIM72 and Caveolin-3 in Antigravitational Soleus Muscle in Mice
Overview
Affiliations
Effects of mechanical loading on the expression level of tripartite motif-containing 72 (TRIM72) and caveolin-3 (Cav-3) in mouse soleus muscle were investigated. Mice were subjected to (1) continuous hindlimb suspension (HS) for 2 weeks followed by 1-week ambulation recovery or (2) functional overloading (FO) on the soleus by cutting the distal tendons of the plantaris and gastrocnemius muscles. Soleus muscle atrophy was induced by 2-week hindlimb suspension (HS). Reloading-associated regrowth of atrophied soleus muscle was observed by 1-week reloading following HS. HS also depressed the expression level of insulin receptor substrate-1 (IRS-1) mRNA, TRIM72, Cav-3, and phosphorylated Akt (p-Akt)/total Akt (t-Akt), but increased the phosphorylated level of p38 mitogen-activated protein kinase (p-p38MAPK) in soleus muscle. Thereafter, the expression level of MyoD mRNA, TRIM72 (mRNA, and protein), and Cav-3 was significantly increased and recovered to the basal level during 1-week reloading after HS. Although IRS-1 expression was also upregulated by reloading, the expression level was significantly lower than that before HS. Significant increase in p-Akt and phosphorylated p70 S6 kinase (p-p70S6K) was observed by 1-day reloading. On the other hand, 1-week functional overloading (FO) induced soleus muscle hypertrophy. In FO-associated hypertrophied soleus muscle, the expression level of IRS-1 mRNA, MyoD mRNA, TRIM72 mRNA, p-Akt, and p-p70S6K was increased, but the expression of Cav-3 and p-p38MAPK was decreased. FO had no effect on the protein expression level of TRIM72. These observations suggest that the loading-associated upregulation of TRIM72 protein in skeletal muscle may depress the regrowth of atrophied muscle via a partial suppression of IRS-1. In addition, downregulation of Cav-3 in skeletal muscle may depress overloading-induced muscle hypertrophy.
Ohno Y, Nakatani M, Matsui Y, Suda Y, Ito T, Ando K In Vivo. 2024; 39(1):218-227.
PMID: 39740887 PMC: 11705108. DOI: 10.21873/invivo.13820.
Abid M, Bredahl E, Clifton A, Qiu H, Andrews M, Checco J J Proteome Res. 2023; 23(1):215-225.
PMID: 38117800 PMC: 10843731. DOI: 10.1021/acs.jproteome.3c00540.
Tastekin B, Pelit A, Sapmaz T, Celenk A, Majeed M, Mundkur L J Diabetes Res. 2023; 2023:6657869.
PMID: 38020198 PMC: 10661870. DOI: 10.1155/2023/6657869.
Tian Y, Zhou C, Bu X, Lv Q, Huang Q J Inflamm Res. 2023; 16:2707-2718.
PMID: 37404717 PMC: 10317540. DOI: 10.2147/JIR.S408681.
Mirzoev T Int J Mol Sci. 2020; 21(21).
PMID: 33114683 PMC: 7663166. DOI: 10.3390/ijms21217940.